Home » Stocks » Yield10 Bioscience

Yield10 Bioscience, Inc. (YTEN)

Stock Price: $6.31 USD 0.04 (0.64%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 12.43M
Revenue (ttm) 861,000
Net Income (ttm) -14.30M
Shares Out 1.97M
EPS (ttm) -19.76
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $6.31
Previous Close $6.27
Change ($) 0.04
Change (%) 0.64%
Day's Open 6.24
Day's Range 6.06 - 6.32
Day's Volume 21,565
52-Week Range 3.50 - 51.20

More Stats

Market Cap 12.43M
Enterprise Value 6.39M
Earnings Date (est) Aug 11, 2020
Ex-Dividend Date n/a
Shares Outstanding 1.97M
Float 1.57M
EPS (basic) -29.22
EPS (diluted) -19.76
FCF / Share -5.15
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 55,581
Short Ratio 0.28
Short % of Float 4.18%
Beta 2.84
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 14.44
PB Ratio 1.32
Revenue 861,000
Operating Income -8.98M
Net Income -14.30M
Free Cash Flow -8.74M
Net Cash 6.04M
Net Cash / Share 3.07
Gross Margin -469.45%
Operating Margin -1,042.86%
Profit Margin -1,660.40%
FCF Margin -1,014.98%
ROA -39.26%
ROE -184.18%
ROIC -121.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 2
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(111.25% upside)
Current: $6.31
Target: 13.33
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth44.96%-41.1%-18.55%-14.15%-51.79%-25.89%-90.87%2803.93%218.08%-
Gross Profit0.810.560.941.161.351.321.8740.351.430.45
Operating Income-8.60-9.32-9.28-10.25-12.47-26.83-28.543.93-38.86-38.94
Net Income-12.96-9.19-9.40-7.60-23.68-29.53-30.513.63-38.79-38.80
Shares Outstanding0.360.
Earnings Per Share-35.50-36.99-131.60-109.20-380.00-1,152.00-2,124.00264.00-2,975.94-3,479.93
Operating Cash Flow-8.65-8.75-8.20-14.40-21.86-24.54-26.65-31.74-31.73-32.00
Capital Expenditures-0.06-0.04-0.01-0.75-0.65-0.13-0.37-0.38-0.90-0.91
Free Cash Flow-8.72-8.80-8.21-15.16-22.52-24.67-27.02-32.12-32.63-32.90
Cash & Equivalents11.456.1014.807.7412.8920.6719.8344.3777.4862.20
Total Debt4.226.47--------
Net Cash / Debt7.23-0.3614.807.7412.8920.6719.8344.3777.4862.20
Book Value-4.095.7013.506.3713.0318.8020.4047.3439.4623.68
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Yield10 Bioscience, Inc.
Country United States
Employees 25
CEO Oliver P. Peoples

Stock Information

Ticker Symbol YTEN
Stock Exchange NASDAQ
Sector Basic Materials
Industry Agricultural Inputs
Unique Identifier NASDAQ: YTEN
IPO Date November 10, 2006


Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for step-changing improvements in crop yield in the United States and Canada. The company, through its Trait Factory, is involved in developing high value seed traits for the agriculture and food industries. It also has an oilseed development center in Saskatchewan, Canada. Yield10 Bioscience, Inc. has research agreements with Bayer AG to develop traits in soybean; Forage Genetics International, LLC to develop traits in forage sorghum; and J. R. Simplot Company to develop novel traits in potato. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was founded in 1992 and is headquartered in Woburn, Massachusetts.